Children Receive Bespoke, Lab-Grown Ears

The tissue, grown on a 3-D scaffold and seeded from the kids’ own cells, was transplanted to correct deformities in their cartilage.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

G. SHOU ET AL., EBIOMEDICINE, DOI:10.1016/J.EBIOME.2018.01.011, 2018Five children have had ear reconstruction using lab-grown cartilage that was seeded from their own cells and grown on 3-D-printed molds, researchers reported in EBioMedicine earlier this month (January 12).

“It’s a very exciting approach,” Tessa Hadlock at the Massachusetts Eye and Ear Infirmary in Boston tells New Scientist. “They’ve shown that it is possible to get close to restoring the ear structure.”

The kids were between the ages of 6 and 10 years old and all had microtia, a malformation of the external ear. The researchers took a sample of cartilage from each child, harvested the cartilage-forming cells (called chondrocytes), expanded them, and then grew them on a mold that was build from a CT scan of the patient’s normal ear. The tissue was then implanted into a skin flap to reconstruct the ear, a process that all told took several months.

The first child has been followed for two and a half years, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies